You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Ovarian Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)

Not yet recruiting
  • Prostate Cancer
  • +11 more
  • Guided physical exercise
  • +2 more
  • Tampere, Länsi-Suomi, Finland
    Tampere University Hospital
Apr 3, 2023

Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3 Trial in Washington, Hackensack (NY-ESO-1 Peptide

Not yet recruiting
  • Ovarian Cancer Stage IV
  • +2 more
  • Washington, District of Columbia
  • +2 more
Jul 28, 2022

Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Ovarian Carcinoma Trial in Ann Arbor

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Mar 31, 2022

Recurrent Gynecological Cancer, Metastatic Cervical Cancer, Metastatic Ovarian Cancer Trial in Boston (Durvalumab, Tremelimumab,

Terminated
  • Recurrent Gynecological Cancer
  • +10 more
  • Boston, Massachusetts
    Martin King
Oct 4, 2022

Ovarian Cancer Trial in Guangzhou

Recruiting
  • Ovarian Cancer
    • Guangzhou, Guangdong, China
      The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit
    Feb 22, 2022

    Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute

    Recruiting
    • Metastatic Colorectal Cancer
    • +4 more
    • Young TIL
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer, HER2-Negative Breast Cancer, Metastatic Epithelial Ovarian Cancer

    Terminated
    • Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Mar 16, 2022

    Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

    Recruiting
    • Advanced Ovarian Carcinoma
    • +7 more
    • Bydgoszcz, Kujawsko-pomorskie, Poland
    • +2 more
    Mar 7, 2023

    Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1

    Not yet recruiting
    • Advanced Fallopian Tube Carcinoma
    • +10 more
    • Wee1 Inhibitor ZN-c3
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jan 25, 2023

    Metastatic Ovarian Cancer, Triple Negative Breast Cancer Trial in Re?ovot (Nerofe is a first in class derivative of a human

    Withdrawn
    • Metastatic Ovarian Cancer
    • Triple Negative Breast Cancer
    • Nerofe is a first in class derivative of a human hormon-peptide(TCApF), with Cancer suppressive properties.
    • Reẖovot, Israel
      Oncologic Institue, Kaplan
    Oct 18, 2021

    Assess Safety and Effectiveness of Zirabev in Domestic Various

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +7 more
    • (no location specified)
    Jun 30, 2022

    1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer Trial in Chongqing (ATG-008,

    Not yet recruiting
    • 1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer
    • Chongqing, Chongqing, China
      Chongqing Cancer Hospital
    Aug 4, 2021

    Recurrent Ovarian Cancer, Recurrent Uterine Cancer, Metastatic Cancer Trial in Toronto (RP-6306, Carboplatin, Paclitaxel)

    Not yet recruiting
    • Recurrent Ovarian Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Oct 25, 2023

    Assessing the Time Demands of Cancer

    Not yet recruiting
    • Metastatic Breast Cancer
    • Ovarian Cancer
      • Birmingham, Alabama
      • +1 more
      Jan 31, 2023

      Ovarian Cancer Trial in Pittsburgh (Carboplatin AUC 5 and paclitaxel, Bintrafusp alfa (M7824))

      Not yet recruiting
      • Ovarian Cancer
      • Carboplatin AUC 5 and paclitaxel
      • Bintrafusp alfa (M7824)
      • Pittsburgh, Pennsylvania
        University of Pittsburgh Medical Center
      Jul 12, 2022

      Ovarian Cancer, Breast Cancer Trial in India (Olaparib)

      Completed
      • Ovarian Cancer
      • Breast Cancer
      • Ahmedabad, India
      • +15 more
      Oct 28, 2022

      Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor Trial (INX-315)

      Not yet recruiting
      • Breast Cancer
      • +8 more
      • (no location specified)
      Feb 9, 2023

      Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer Trial (AsiDNA, Olaparib)

      Not yet recruiting
      • Metastatic Castration-resistant Prostate Cancer
      • +2 more
      • (no location specified)
      Jan 17, 2023

      Metastatic Fallopian Tube Carcinoma, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma Trial in United

      Active, not recruiting
      • Metastatic Fallopian Tube Carcinoma
      • +11 more
      • Phoenix, Arizona
      • +13 more
      Dec 2, 2022

      Immunotherapy-related CRP Kinetics in Metastatic Gynecological

      Recruiting
      • Gynecological Malignancies
      • +4 more
        • Tuebingen, Germany
          Department of Women's Health
        Jun 13, 2023

        Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

        Recruiting
        • Advanced Pancreatic Carcinoma
        • +27 more
        • Gainesville, Florida
        • +3 more
        Jan 3, 2023

        Ovarian Cancer, Breast Cancer Trial in Vijayawada (Olaparib tablets, 150 mg, Lynparza® (olaparib) tablets 150 mg)

        Recruiting
        • Ovarian Cancer
        • Breast Cancer
        • Olaparib tablets, 150 mg
        • Lynparza® (olaparib) tablets 150 mg
        • Vijayawada, Andhra Pradesh, India
          Sandoz Investigative Site
        Apr 12, 2022

        BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

        Recruiting
        • BRCA1 Gene Mutation
        • +19 more
        • Laboratory Biomarker Analysis
        • Pembrolizumab
        • New Brunswick, New Jersey
        • +1 more
        Nov 16, 2022

        Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)

        Completed
        • Carcinoma
        • +12 more
        • Ocoxin-Viusid
        • Havana, Cuba
          National Institute of Oncology and Radiobiology (INOR)
        Jul 5, 2022